Atlas Trials

A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

Clinical trial NCT00880841 · COMPLETED

Trial details

NCT number
NCT00880841
Sponsor
NanoSHIFT LLC
Status
COMPLETED
Study type
OBSERVATIONAL
Healthy
Start date
2009-04-01
Primary completion
2009-05-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.